Diagnostic and predictive value of skin testing in platinum salt hypersensitivity

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 3, 2007, Pages 726-730

  Leguy Seguin, Vanessa ^a   Jolimoy, Genevieve ^b   Coudert, Bruno ^d   Pernot, Corine ^c   Dalac, Sophie ^a   Vabres, Pierre ^a   Collet, Evelyne ^a  

^a Dermatology Department   (France)

^b Pharmacology Department

^c University Hospital   (France)

^d CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

anaphylaxis; Drug hypersensitivity; intradermal test; patch tests; platinum salts; prick tests

Indexed keywords

CARBOPLATIN; CARBOPLATINE TEVA; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; FLUOROURACIL; GEMCITABINE; OXALIPLATIN; PACLITAXEL; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANAPHYLACTIC SHOCK; ANGINA PECTORIS; ANGIONEUROTIC EDEMA; ARTICLE; BRONCHOSPASM; CHILL; CLINICAL ARTICLE; COLORECTAL CANCER; DIAGNOSTIC VALUE; DIARRHEA; DIZZINESS; DRUG HYPERSENSITIVITY; DYSPNEA; ECZEMA; ERYTHEMA; FEMALE; FEVER; GYNECOLOGIC CANCER; HUMAN; HYPEREOSINOPHILIA; HYPERTENSION; HYPOTENSION; INTRACUTANEOUS TEST; LUNG CANCER; MACULOPAPULAR RASH; MALE; NAUSEA; PANCREAS CANCER; PATCH TEST; PREDICTION; PRIORITY JOURNAL; PRURITUS; RASH; TACHYCARDIA; TONGUE EDEMA; URTICARIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CISPLATIN; CROSS REACTIONS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PLATINUM; PROGNOSIS; PROSPECTIVE STUDIES; SALTS; SKIN TESTS;

EID: 33847315980     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.11.640     Document Type: Article

References (23)

1. Sliesoraitis S., and Chikhale P.J. Carboplatin hypersensitivity. Int J Gynecol Cancer 15 (2005) 13-18
2. Zanotti K.M., Rybicki L.A., Kennedy A.W., Belinson J.L., Webster K.D., Kulp B., et al. Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol 19 (2001) 3126-3129
3. Markman M., Kennedy A., Webster K., Elson P., Peterson G., Kulp B., et al. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol 17 (1999) 1141
4. Maindrault-Goebel F., Andre T., Tournigand C., et al. Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients. Eur J Cancer 41 (2005) 2262-2267
5. Lenz G., Hacker U.T., Kern W., Schalhorn A., and Hiddemann W. Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution. Anticancer Drugs 14 (2003) 731-733
6. Basu R., Rajkumar A., and Ranjan Datta N. Anaphylaxis to cisplatin following nine previous uncomplicated cycles. Int J Clin Oncol 7 (2002) 365-367
7. Santini D., Tonini G., Salerno A., et al. Idiosyncratic reaction after oxaliplatin infusion. Ann Oncol 12 (2001) 132-133
8. Thomas R.R., Quinn M.G., Schuler B., and Grem J.L. Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer 97 (2003) 2301-2307
9. Petit-Laurent F., Conroy T., Krakowski I., Barbaud A., and Trechot P. Delayed urticaria with oxaliplatin. Gastroenterol Clin Biol 24 (2000) 851-852
10. Barbaud A., Goncalo M., Bruynzeel D., and Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 45 (2001) 321-328
11. Bégaud B., Evreux J.C., Jouglard J., and Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Thérapie 40 (1985) 111-118
12. Khan A., Hill J.M., Grater W., Loeb E., MacLellan A., and Hill N. Atopic hypersensitivity to cis-dichlorodiammineplatinum (II) and other platinum complexes. Cancer Res 35 (1975) 2766-2770
13. Markman M., Zanotti K., Kulp B., and Peterson G. Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity. Gynecol Oncol 89 (2003) 514-516
14. Newman Taylor A.J., Cullinan P., Lympany P.A., Harris J.M., Dowdeswell R.J., and du Bois R.M. Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts. Am J Respir Crit Care Med 160 (1999) 435-438
15. Markman M., Zanotti K., Peterson G., Kulp B., Webster K., and Belinson J. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol 21 (2003) 4611-4614
16. Weidmann B., Mulleneisen N., Bojko P., and Niederle N. Hypersensitivity reactions to carboplatin: report of two patients, review of the literature, and discussion of diagnostic procedures and management. Cancer 73 (1994) 2218-2222
17. Sood A.K., Gelder M.S., Huang S.W., and Morgan L.S. Anaphylaxis to carboplatin following multiple previous uncomplicated courses. Gynecol Oncol 57 (1995) 131-132
18. Menczer J., Barda G., Glezerman M., et al. Hypersensitivity reaction to carboplatin: results of skin tests. Eur J Gynaecol Oncol 20 (1999) 214-216
19. Garufi C., Cristaudo A., Vanni B., et al. Skin testing and hypersensitivity reactions to oxaliplatin. Ann Oncol 14 (2003) 497-498
20. Zweizig S., Roman L.D., and Muderspach L.I. Death from anaphylaxis to cisplatin: a case report. Gynecol Oncol 53 (1994) 121-122
21. Dizon D.S., Sabbatini P.J., Aghajanian C., Hensley M.L., and Spriggs D.R. Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy. Gynecol Oncol 84 (2002) 378-382
22. Porzio G., Marchetti P., Paris I., Narducci F., Ricevuto E., and Ficorella C. Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin. Eur J Gynaecol Oncol 23 (2002) 335-336
23. Gottlieb M.J., Nelson B., and Perry W. Utility of skin test for allergy to carboplatin or cisplatin. J Allergy Clin Immunol 101 (1998) S139